Niven Abby Sarah Macnish
CIK: 0002126048
Transaction Breakdown
Open Market Buys (P)0
High conviction signal
Open Market Sales (S)0
Position reduction
Option Exercises (M)0
Derivative conversions
Awards (A)0
Compensation grants
Other (G, F, J, C, D, …)0
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ATHE
ALTERITY THERAPEUTICS LTD
Officer
Discretionary Trading P&L
Holdings
Transaction History (0 total)
1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024.
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| 1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024. | ||||||
0-0 of 0 transactions
About Macnish Niven Abby Sarah
Macnish Niven Abby Sarah (SEC CIK 0002126048) files insider reports with the SEC as Chief Financial Officer of ALTERITY THERAPEUTICS LTD (ATHE).
Signal8 holds 1 ownership filing by Macnish Niven Abby Sarah, a Form 3, filed on Apr 9, 2026. A Form 3 is an initial statement of ownership: it reports holdings, not trades, so no Form 4 or Form 5 transactions are on record since Sep 2024.
The business address on Macnish Niven Abby Sarah's filings is in MELBOURNE.
Other insiders filing for ALTERITY THERAPEUTICS LTD (ATHE)
- Marks Peter Ashley, Director
- Stamler David Allen, Chief Executive Officer
- Babarczy Julian Michael, Director
- Gozlan Lawrence Bernard, Director
- Cunningham Ann Michelle, Director